Related content

Central administration of -melanocyte stimulating hormone inhibits fasting- and neuropeptide Y-induced feeding in neonatal chicks

By Kawakami S.-i.   Bungo T.   Ando R.   Ohgushi A.   Shimojo M.   Masuda Y.   Furuse M.  

European Journal of Pharmacology, Vol. 398, Iss. 3, 2000-06 ,pp. : 361-364

Elsevier

Access to resources Recommend Favorite

The administration of -melanocyte-stimulating hormone protects the ischemic/reperfused myocardium

By Vecsernyes M.   Juhasz B.   Der P.   Kocsan R.   Feher P.   Bacskay I.   Kovacs P.   Tosaki A.  

European Journal of Pharmacology, Vol. 470, Iss. 3, 2003-06 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

The receptor ligand rimcazole alters secretion of prolactin and -melanocyte stimulating hormone by dopaminergic and non-dopaminergic mechanisms

By Eaton M.J.   Lookingland K.J.   Moore K.E.  

European Journal of Pharmacology, Vol. 299, Iss. 1, 1996-03 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite

Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes

By Schioth H.B.   Mutulis F.   Muceniece R.   Prusis P.   Wikberg J.E.S.  

European Journal of Pharmacology, Vol. 349, Iss. 2, 1998-05 ,pp. : 359-366

Elsevier

Access to resources Recommend Favorite

GABAergic system and imipramine-induced impairment of memory retention in rats

By Zarrindast M.R.   Shamsi T.   Azarmina P.   Rostami P.   Shafaghi B.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 59-64

Elsevier

Access to resources Recommend Favorite